Israel Is Researching The Most Effective Vaccine For COVID-19 Up To 94 Percent

JAKARTA - Israel is conducting research to create the most potential COVID-19 vaccine through its health firm called Clalit. The top health institution in Israel announced a vaccine that can reduce symptoms of COVID-19 infection by 94 percent.

Previously, Clalit gave vaccines to about 600.000 residents. It proved effective with a high degree of accuracy. The Clalit health institute provides two doses of vaccine to Israelis. From the results of these studies, it turns out that the Pfizer vaccine has an efficacy of up to 94 percent.

This research by Clalit is the largest research ever conducted in Israel. The reason is that they conducted research on half of the Israeli citizens from the total.

"This clearly shows that the Pfizer coronavirus vaccine is very effective in real world a week after the second dose, as found in clinical studies", said Ran Balicer, Head of Innovation at Clalit, as quoted by Reuters, Monday, February 14.

Pfizer is a vaccine developed by BioNTech Germany. Based on research conducted by Israel, it appears to be effective after the second dose is injected.

Meanwhile, experts conducting research at other Israeli institutions such as the Weizmann Institute of Science report that there has been a drastic reduction in hospitalized patients as well as those with serious symptoms experienced by the elderly group who have been vaccinated.

Unfortunately, patients from among the young age group are still experiencing a serious increase because they have not been vaccinated. Next week, the Israeli government will administer vaccines to young age groups.